Novera Retatrutide: A promising New Hope for Weight Management?
Recent clinical information suggests that Novera Retatrutide, a dual-action therapy from Novo Nordisk, could provide a significant advance in body loss. Differing from many existing drugs, Retatrutide impacts both glucagon-like peptide-1 (GLP-1) and GIP, potentially producing to improved losses i